logo-loader
ASX:RCE OTC:RECEF

Recce Pharmaceuticals Ltd

Receive alerts
Market:
ASX
Price
0.38 AUD
Day Change
1.35%
Market Cap:
$114.69 m
52 weeks high
0.73
52 weeks low
0.27

In brief

Recce Pharmaceuticals Ltd (ASX:RCE) is developing a new class of synthetic anti-infectives designed to address the urgent global health threat of antibiotic-resistant superbugs.

Snapshot

  • Recce’s R327G gains commercial pathway with Arrotex - ICYMI
  • Recce Pharmaceuticals advances R327 as diabetes and antibiotic resistance burdens converge
  • Vietnam Patent strengthens Recce’s ASEAN strategy